Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAMPT | P43490 | 2/20 | 0.45 |
| ▸ | CYP17A1 | P05093 | 4/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | BRS3 | P32247 | 1/20 | 0.39 |
| ▸ | METAP1 | P53582 | 1/20 | 0.39 |
| ▸ | ATR | Q13535 | 1/20 | 0.39 |
| ▸ | LATS1 | O95835 | 2/20 | 0.38 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5776099 | 0.89 | NAMPT (0.45) | NAMPTCYP17A1RAB9ABRS3METAP1 | |
| SCHEMBL29706100 | 0.87 | NAMPT (0.46) | NAMPTCYP17A1RAB9ABRS3METAP1 | |
| SCHEMBL2353760 | 0.87 | NAMPT (0.46) | NAMPTCYP17A1RAB9ABRS3METAP1 | |
| SCHEMBL29374493 | 0.83 | KMT2A (0.46) | NAMPTCYP17A1METAP1AAK1 | |
| SCHEMBL18832828 | 0.83 | NAMPT (0.43) | NAMPTCYP17A1RAB9ABRS3METAP1 | |
| SCHEMBL22498343 | 0.83 | KMT2A (0.46) | NAMPTCYP17A1METAP1AAK1 | |
| SCHEMBL18522430 | 0.83 | NAMPT (0.50) | NAMPTCYP17A1RAB9ABRS3METAP1 | |
| SCHEMBL4037373 | 0.82 | NAMPT (0.47) | NAMPTCYP17A1RAB9ABRS3METAP1 | |
| SCHEMBL3666785 | 0.81 | NAMPT (0.48) | NAMPTCYP17A1RAB9ABRS3METAP1 | |
| SCHEMBL2107971 | 0.81 | NAMPT (0.48) | NAMPTCYP17A1RAB9ABRS3METAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1673088-A1 | 1,1,1- TRIFLUORO-4-PHENYL-4-METHYL-2-(1H-PYRROLO¬2,3-C|PYRIDIN-2-YLMETHYL)PENTAN-2-OL DERIVATIVES AND RELATED COMPOUNDS AS GLUCOCORTICOID LIGANDS FOR THE TREATMENT OF INFLAMMATORY DISEASES AND DIABETES | BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) | 2006-06-28 | — | — | EP | disclosed |
| WO-2005030213-A1 | 1,1,1-TRIFLUORO-4-PHENYL-4-METHYL-2-(1H-PYRROLO | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2005-04-07 | — | — | WO | disclosed |